| First Author | Hai L | Year | 2018 |
| Journal | Genesis | Volume | 56 |
| Issue | 8 | Pages | e23223 |
| PubMed ID | 30004627 | Mgi Jnum | J:265806 |
| Mgi Id | MGI:6200593 | Doi | 10.1002/dvg.23223 |
| Citation | Hai L, et al. (2018) A mouse model engineered to conditionally express the progesterone receptor-B isoform. Genesis 56(8):e23223 |
| abstractText | Using a Rosa26 gene targeting strategy in mouse embryonic stem cells, we have generated a new transgenic mouse (Pgr-B (LSL) ), which is designed to conditionally express the epitope-tagged mouse progesterone receptor-B (PGR-B) isoform when crossed with a specific cre driver mouse. To functionally validate this transgenic mouse, we crossed the Pgr-B (LSL) mouse with the MMTV-CREA transgenic mouse to create the MMTV-CREA/Pgr-B (LSL) bigenic (termed PR-B:OE to denote PGR-B overexpressor). As expected, transgene-derived PGR-B protein was specifically targeted to the virgin mammary gland epithelium. At a functional level, the PR-B:OE bigenic exhibited abnormal mammary morphogenesis-dilated epithelial ducts, precocious alveologenesis and lateral side-branching, along with a prominent proliferative signature-that resulted in pregnant PR-B:OE mice unable to exhibit mammary gland terminal differentiation at parturition. Because of this developmental failure, the PR-B:OE mammary gland was incapable of producing milk resulting in early neonatal death of otherwise healthy litters. This first line of analysis demonstrates the utility of the Pgr-B (LSL) mouse to examine the role of the PGR-B isoform in different physiologic and pathophysiologic systems that are responsive to progesterone. |
